Dunvegan Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $3.49M | Sell |
41,378
-423
| -1% | -$35.6K | 4.1% | 5 |
|
|
2015
Q3 | $3.5M | Buy |
41,801
+1,611
| +4% | +$135K | 3.99% | 6 |
|
|
2015
Q2 | $3.36M | Hold |
40,190
| – | – | 3.71% | 8 |
|
|
2015
Q1 | $2.92M | Sell |
40,190
-827
| -2% | -$60.1K | 2.58% | 11 |
|
|
2014
Q4 | $2.83M | Sell |
41,017
-3,191
| -7% | -$220K | 2.46% | 10 |
|
|
2014
Q3 | $2.87M | Sell |
44,208
-73
| -0.2% | -$4.73K | 2.59% | 11 |
|
|
2014
Q2 | $2.75M | Sell |
44,281
-2,877
| -6% | -$179K | 2.3% | 11 |
|
|
2014
Q1 | $2.78M | Sell |
47,158
-4,061
| -8% | -$239K | 2.34% | 11 |
|
|
2013
Q4 | $2.61M | Sell |
51,219
-462
| -0.9% | -$23.6K | 2.15% | 15 |
|
|
2013
Q3 | $2.6M | Sell |
51,681
-193
| -0.4% | -$9.71K | 1.92% | 19 |
|
|
2013
Q2 | $2.55M | Buy |
+51,874
| New | +$2.55M | 1.97% | 19 |
|